BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20130088)

  • 1. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
    Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
    Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
    Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
    Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.
    Marconett CN; Sundar SN; Tseng M; Tin AS; Tran KQ; Mahuron KM; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2011 Sep; 32(9):1315-23. PubMed ID: 21693539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.
    Marconett CN; Singhal AK; Sundar SN; Firestone GL
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):74-84. PubMed ID: 22835548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells.
    Xue L; Schaldach CM; Janosik T; Bergman J; Bjeldanes LF
    Chem Biol Interact; 2005 Apr; 152(2-3):119-29. PubMed ID: 15840385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
    Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-3-carbinol induces tumor cell death: function follows form.
    Megna BW; Carney PR; Nukaya M; Geiger P; Kennedy GD
    J Surg Res; 2016 Jul; 204(1):47-54. PubMed ID: 27451867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha as a target for indole-3-carbinol.
    Wang TT; Milner MJ; Milner JA; Kim YS
    J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).
    Qi J; Huo L; Zhu YT; Zhu YJ
    J Biol Chem; 2014 Nov; 289(45):31373-81. PubMed ID: 25258321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
    Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
    Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.
    Marques M; Laflamme L; Benassou I; Cissokho C; Guillemette B; Gaudreau L
    BMC Cancer; 2014 Jul; 14():524. PubMed ID: 25048790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.
    Cover CM; Hsieh SJ; Tran SH; Hallden G; Kim GS; Bjeldanes LF; Firestone GL
    J Biol Chem; 1998 Feb; 273(7):3838-47. PubMed ID: 9461564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the regulatory connections between two controllers of breast cancer cell fate.
    Lee J; Tiwari A; Shum V; Mills GB; Mancini MA; Igoshin OA; Balázsi G
    Nucleic Acids Res; 2014 Jun; 42(11):6839-49. PubMed ID: 24792166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.